BGFT - opening trades this a.m. (opened at .00355, an mm

New Post Public Reply Private Reply Replies (0) Message Board
4 MY T
253
BGFT - opening trades this a.m. (opened at .00355, an mm trade for 200 shares)

MM signals:

300 > bring the price down at least 30%
600 > provide resistance
900 > let the stock float.

MM SIGNALS
100 > I need shares
200 > I need shares badly but dont take it down to get em
300 > Take the price down to get shares....
400 > Trade it sideways based on Supply and Demand
500 > Gap one way or the other, usually to the direction
of the 500 trade. Sometimes -if in the middle -keep the price right where it is.



09:48:18 0.0006 645000 OTO
09:45:24 0.0006 350000 OTO
09:45:21 0.0006 150000 OTO
09:43:40 0.0005 2515000 OTO
09:42:07 0.0005 500000 OTO
09:41:03 0.0006 1000000 OTO
09:35:51 0.0006 500000 OTO
09:33:36 0.0006 90000 OTO
09:33:16 0.0006 1180000 OTO
09:33:12 0.0006 748333 OTO
09:32:49 0.0006 100000 OTO
09:32:04 0.0006 5140000 OTO
09:31:46 0.0006 2666000 OTO
09:30:24 0.0007 234128 OTO
09:30:13 0.0006 5327300 OTO
09:30:12 0.0006 1755000 OTO
09:30:12 0.0007 10866666 OTO
09:30:04 0.0006 1000000 OTO
09:30:04 0.0006 1000000 OTO
09:30:04 0.0006 100000 OTO
09:30:03 0.0008 100000 OTO
09:30:02 0.00355 200 OTO
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Concerns Rise Over Trump's Cryptocurrency Reserve Strategy

Updated Category News Views 192

Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...

Continue Reading
BriaCell Joins Prestigious Program to Boost Cancer Treatments

Updated Category News Views 145

BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...

Continue Reading
Exploring Current Net Asset Values of WisdomTree Funds

Updated Category News Views 114

Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...

Continue Reading
DoorDash's Innovative Tools Transforming Restaurant Dynamics

Updated Category News Views 208

Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...

Continue Reading
Mezzion's Udenafil Shows Promise in ADPKD Study

Updated Category News Views 34

Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...

Continue Reading